SGK1 and cancer: We propose that aberrant SGK1 could affect reciprocal SGK1-FOXO3A-Akt regulation and, hence, further studies of ANXA7 TSG effects may lead to the compelling therapeutic modulation of SGK1/FOXO3A-mediated cell survival in cancer cells.